Assessment of lipid-lowering treatment in Bulgaria - The CEPHEUS study

Central European Journal of Medicine

Volumn 8, Issue 5, 2013, Pages 627-637

  Gotcheva, Nina N ^a   Raev, Dimitar H ^b   Trendafilova, Elina G ^a   Postadzhiyan, Arman S ^c   Runev, Nikolay M ^d   Vandenhoven, Guy ^e   Temmerman, Anne Marie ^e   Staneva, Marina P ^e  

^a NATIONAL HEART HOSPITAL   (Bulgaria)

^b Medical Institute of Ministry of Internal Affairs   (Bulgaria)

^c MHAT St Anna   (Bulgaria)

^d MHAT Aleksandrovska ^*  (Bulgaria)

^e ASTRAZENECA   (United Kingdom)

Author keywords

Bulgaria; Dyslipidaemia management; Guidelines; Hypercholesterolaemia; LDL goal; Lipid lowering drugs; Pharmacoepidemiology

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BILE ACID SEQUESTRANT; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BULGARIA; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MONOTHERAPY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION;

EID: 84885189597     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-013-0215-0     Document Type: Article

References (19)

1. Sans S, Kesteloot H, Kromhout D on behalf of the Task Force. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Euro Heart J. 1997; 18:1231-1248
2. British Heart Foundation. European Cardiovascular Disease Statistics. British Heart Foundation, London 2005. (http://www.bhf.org.uk/cvc/pdf/CVC- 10Years-2008-v2.pdf)
3. Scheen AJ, Kulbertus H. Interheart: nine risk factors predict nine out of ten myocardial infarctions. Rev Med Liege. 2004; 59:676-679
4. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994; 308:367-372
5. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003; 326:1423
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360:7-22
7. EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Euro Heart J. 1997; 18:1569-1582
8. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Euro Heart J. 2001; 22:554-572
9. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009; 16:121-137
10. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U. EUROASPIRE Study Group. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010; 17:530-540
11. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia among US Adults. Findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003; 107:2185-2189
12. Pearson TA, Laurora I, Chu H, Kafonek S. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000; 160:459-467
13. Frolkis JP, Pearce GL, Nambi V, Minor S, Sprecher DL. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med. 2002; 113:625-629
14. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A. European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (Constituted by representatives of nine societies and by invited experts). Euro Heart J. 2007; 28:2375-2414
15. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and, treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002; 106:3143-3421
16. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227-239
17. Hermans MP, Van Mieghem W, Vandenhoven G, Vissers E. Centralized Pan-european survey on tHE Undertreatment of hypercholesterolemia (CEPHEUS). Acta Cardiol. 2009; 64:2 (177-185)
18. Hermans MP, Castro Cabezas M, Strandberd T, Ferrires J, Feely J, Elisaf M, Michel G, Sansoy V. Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS): Overall findings from eight countries. Curr Med Res Opin. 2010; 26:2 (445-454)
19. Elisaf MS, Nikas N. Centralized pan-European survey on the under-treatment of hypercholesterolemia in patients using lipid lowering drugs-the CEPHEUS - Greece survey. Angiology. 2010; 61:5 (465-474)